Tamsulosin

Overview

Tamsulosin is a selective alpha-1A and alpha-1B adrenoceptor antagonist that exerts its greatest effect in the prostate and bladder, where these receptors are most common. It is indicated for the treatment of signs and symptoms of benign prostatic hypertrophy. Antagonism of these receptors leads to relaxation of smooth muscle in the prostate and detrusor muscles in the bladder, allowing for better urinary flow. Other alpha-1 adrenoceptor antagonists developed in the 1980s were less selective and more likely to act on the smooth muscle of blood vessels, resulting in hypotension. Tamsulosin was first approved by the FDA on April 15, 1997.

Indication

Tamsulosin is indicated for the treatment of signs and symptoms of benign prostatic hyperplasia. Tamsulosin is also used off label for the treatment of ureteral stones, prostatitis, and female voiding dysfunction.

Associated Conditions

Benign Prostatic Hyperplasia (BPH)
Benign Prostatic Hypertrophy
Bladder Outlet Obstruction
Ureteral Calculus

Clinical Trials

View More Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Actual Use Study of Tamsulosin in Men	2015/10/09	NCT02573311	Phase 3	Completed	Boehringer Ingelheim
Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers	2015/08/20	NCT02529800	Phase 1	Completed	Hanmi Pharmaceutical Company Limited
Trial of Prophylactic Tamsulosin for Postoperative Urinary Retention in Primary Total Hip and Knee Arthroplasty Patients	2015/08/10	NCT02518971	Phase 3	Terminated	University of Michigan
Prevention of Post-operative Urinary Retention	2015/07/01	NCT02486653	Phase 3	Completed	University of Wisconsin, Madison
Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population	2015/06/29	NCT02483793	Not Applicable	UNKNOWN	Phoenix Children's Hospital
Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression	2015/05/14	NCT02443844	Phase 4	UNKNOWN	Diskapi Teaching and Research Hospital
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.	2015/04/16	NCT02417831	Phase 1	Completed	Boehringer Ingelheim
Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male.	2015/04/16	NCT02417844	Phase 1	Completed	Boehringer Ingelheim
Silodosin Versus Tamsulosin for Treatment of Ureteral Stones	2015/02/24	NCT02369744	Phase 4	Terminated	Albert Einstein Healthcare Network
Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS	2014/12/01	NCT02303769	Phase 3	Completed	GL Pharm Tech Corporation

FDA Drug Approvals

View More FDA Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
TAMSULOSIN HYDROCHLORIDE	Proficient Rx LP	71205-748	ORAL	0.4 mg in 1 1	1/1/2023
TAMSULOSIN HYDROCHLORIDE	H.J. Harkins Company, Inc.	52959-034	ORAL	0.4 mg in 1 1	1/19/2012
TAMSULOSIN HYDROCHLORIDE	DIRECT RX	61919-703	ORAL	0.4 mg in 1 1	11/9/2018
Tamsulosin hydrochloride	Aphena Pharma Solutions - Tennessee, LLC	43353-663	ORAL	0.4 mg in 1 1	4/30/2014
Tamsulosin Hydrochloride	Bryant Ranch Prepack	71335-0398	ORAL	0.4 mg in 1 1	9/9/2021
FLOMAX	RedPharm Drug, Inc.	67296-1803	ORAL	0.4 mg in 1 1	1/21/2022
Tamsulosin Hydrochloride	A-S Medication Solutions	50090-1846	ORAL	0.4 mg in 1 1	11/17/2023
Tamsulosin Hydrochloride	NuCare Pharmaceuticals,Inc.	68071-2197	ORAL	0.4 mg in 1 1	7/7/2021
Flomax	Physicians Total Care, Inc.	54868-4356	ORAL	0.4 mg in 1 1	9/2/2010
Tamsulosin Hydrochloride	RedPharm Drug, Inc.	67296-1155	ORAL	0.4 mg in 1 1	1/20/2022

EMA Drug Approvals

View More EMA Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

View More HSA Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

View More NMPA Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

View More PPB Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

View More TGA Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

AI-Powered Research

Premium Access